VEA
IGMS

Virtus ETF Advisers’s IGM Biosciences IGMS Stock Holding History

Virtus ETF Advisers’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,649
Closed -$52.8K – 593
2024
Q4 		$52.8K Sell
8,649
-2,957
-25% -$35.1K 0.02% 457
2024
Q3 		$192K Buy
11,606
+205
+2% +$2.25K 0.09% 273
2024
Q2 		$78.3K Sell
11,401
-1,931
-14% -$16.5K 0.04% 412
2024
Q1 		$129K Sell
13,332
-911
-6% -$10.6K 0.07% 343
2023
Q4 		$118K Buy
14,243
+4,334
+44% +$25.2K 0.08% 323
2023
Q3 		$82.7K Sell
9,909
-987
-9% -$8.37K 0.05% 355
2023
Q2 		$101K Buy
10,896
+5,783
+113% +$64.8K 0.06% 377
2023
Q1 		$70.3K Sell
5,113
-1,965
-28% -$40.6K 0.04% 403
2022
Q4 		$120K Sell
7,078
-241
-3% -$4.82K 0.06% 414
2022
Q3 		$166K Buy
7,319
+52
+0.7% +$1.05K 0.07% 340
2022
Q2 		$131K Buy
7,267
+1,798
+33% +$32K 0.05% 348
2022
Q1 		$146K Sell
5,469
-318
-5% -$5.92K 0.07% 229
2021
Q4 		$170K Buy
5,787
+3,574
+162% +$178K 0.06% 283
2021
Q3 		$146K Sell
2,213
-115
-5% -$8.8K 0.06% 347
2021
Q2 		$194K Sell
2,328
-1,106
-32% -$81.9K 0.08% 362
2021
Q1 		$263K Buy
3,434
+60
+2% +$5.46K 0.11% 276
2020
Q4 		$298K Sell
3,374
-1,559
-32% -$110K 0.12% 215
2020
Q3 		$364K Sell
4,933
-659
-12% -$39K 0.19% 182
2020
Q2 		$408K Buy
+5,592
New +$340K 0.19% 191

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Virtus ETF Advisers's IGMS Position: Q1 2025 in Review

Virtus ETF Advisers sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 8,649 shares — an estimated $52.8K sold.

Virtus ETF Advisers first reported a position in IGMS in Q2 2020 and held it in 19 quarters. The position peaked at $408K in Q2 2020. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Virtus ETF Advisers reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 8,649 IGM Biosciences shares in Q1 2025, an estimated $52.8K.
  • Virtus ETF Advisers first reported a position in IGM Biosciences in Q2 2020 and held it in 19 quarters.
  • Virtus ETF Advisers's IGM Biosciences position peaked at $408K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.